Prelude Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
2018
Q3
$786K Sell
2018
Q2
$721K Sell
2018
Q1
$478K Buy
2017
Q4
$183K Buy
2017
Q3
$1K Sell
2017
Q2
$2K Sell
2017
Q1
$31K Buy
2015
Q2
Sell
2015
Q1
$49K Buy
2014
Q4
Sell
2014
Q3
$99K Sell
2014
Q2
$119K Buy
2014
Q1
$106K Buy
2013
Q4
Hold